HMS Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,000
Closed -$778K 173
2019
Q4
$778K Sell
7,000
-22,736
-76% -$2.34M 0.33% 71
2019
Q3
$3.11M Buy
29,736
+13,893
+88% +$1.38M 1.16% 11
2019
Q2
$1.57M Sell
15,843
-1,409
-8% -$134K 0.68% 34
2019
Q1
$1.9M Sell
17,252
-12,414
-42% -$1.3M 0.81% 33
2018
Q4
$3M Buy
29,666
+14,972
+102% +$1.51M 1.51% 14
2018
Q3
$1.62M Buy
14,694
+1,245
+9% +$130K 0.8% 38
2018
Q2
$1.26M Sell
13,449
-158
-1% -$13.6K 0.71% 46
2018
Q1
$1.13M Buy
13,607
+998
+8% +$88.7K 0.75% 49
2017
Q4
$1.15M Buy
+12,609
New +$1.05M 0.86% 38

Other funds holding PRAH

HMS Capital Management's PRAH Position: Q1 2020 in Review

HMS Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 7,000 shares — an estimated $778K sold.

HMS Capital Management first reported a position in PRAH in Q4 2017 and held it in 9 quarters. The position peaked at $3.11M in Q3 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • HMS Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • HMS Capital Management sold 7,000 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $778K.
  • HMS Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 9 quarters.
  • HMS Capital Management's PRA Health Sciences, Inc. position peaked at $3.11M in Q3 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on HMS Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.